Matthew Davis
Family Medicine · Rochester, NYNPI 1700968401
Payments from drug & device makers
Across 8,449 payments — averaging $9069.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$16.4M
- Pfizer$14.9M
- Janssen Research & Development, LLC$13M
- GSK$9.4M
- Valneva Austria GmbH$4.8M
- Sanofi Pasteur Inc.$3.9M
- plus $14.3M from 27 others
Across 36 payments — averaging $14,686 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Valneva Austria GmbH$502K
- Eli Lilly$20K
- Pfizer$6K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$76,627,627 in reported general payments places this provider in the 95th percentile of 4,321 family medicine providers in New York.
Other family medicine in Rochester
- Frank EderBinghamton$46.2M
- Suchet PatelEndwell$23.3M
- James WildGowanda$2.2M
- Michael FedericoEndwell$1.4M
- Donald BrautigamWestfield$1.3M
- Kimberly DesantisEndwell$1.1M
- Michael TugetmanHartsdale$1M
- Richard RuhOrchard Park$769K
- Eric LorraineEndwell$740K
- Louis BonavitaEast Syracuse$674K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.